SCHEMBL71690

SCHEMBL71690

C=Cc1ccc(C(=O)OCOC2Cc3ccccc3C2)cc1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 2/20 0.39
TAS1R1 Q7RTX1 2/20 0.39
SNCA P37840 1/20 0.36
ALDH1A1 P00352 1/20 0.35
CYP3A4 P08684 1/20 0.35
OPRD1 P41143 1/20 0.34
TDP1 Q9NUW8 2/20 0.33
MAPT P10636 1/20 0.33
LMNA P02545 1/20 0.33
PRMT5 O14744 1/20 0.33
WDR77 Q9BQA1 1/20 0.33
PRKCA P17252 1/20 0.33
KMT2A Q03164 2/20 0.33
MEN1 O00255 1/20 0.33
MAPK1 P28482 1/20 0.33
HIF1A Q16665 1/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A3 Q01959 1/20 0.33
IDO1 P14902 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26810445 0.78 SNCA (0.49) TAS1R3TAS1R1SNCAALDH1A1CYP3A4
SCHEMBL92302 0.77 TAS1R3 (0.55) TAS1R3TAS1R1ALDH1A1TDP1MAPT
SCHEMBL92300 0.76 FFAR1 (0.39) ALDH1A1OPRD1TDP1MAPTLMNA
SCHEMBL71831 0.74 CYP3A4 (0.40) ALDH1A1CYP3A4TDP1PRMT5
SCHEMBL16694220 0.72 TAS1R3 (0.47) TAS1R3TAS1R1SNCAALDH1A1CYP3A4
SCHEMBL14825850 0.72 TAS1R3 (0.40) TAS1R3TAS1R1ALDH1A1TDP1MAPT
SCHEMBL26417020 0.71 SNCA (0.49) TAS1R3TAS1R1SNCAALDH1A1CYP3A4
SCHEMBL19294789 0.71 SNCA (0.43) TAS1R3TAS1R1SNCAALDH1A1CYP3A4
SCHEMBL73893 0.71 ALDH1A1 (0.38) ALDH1A1TDP1PRMT5WDR77IDO1
SCHEMBL31719483 0.70 TDP1 (0.52) ALDH1A1TDP1LMNAKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8129086-B2 Polymerizable compound, polymer, positive resist composition, and patterning process using the same SHIN-ETSU CHEMICAL CO., LTD. (JP) 2012-03-06 US disclosed
US-8129086-B2 Polymerizable compound, polymer, positive resist composition, and patterning process using the same SHIN-ETSU CHEMICAL CO., LTD. (JP) 2012-03-06 US disclosed
US-8129086-B2 Polymerizable compound, polymer, positive resist composition, and patterning process using the same SHIN-ETSU CHEMICAL CO., LTD. (JP) 2012-03-06 US disclosed
US-20090297979-A1 Polymerizable compound, polymer, positive resist composition, and patterning process using the same SHIN-ETSU CHEMICAL CO., LTD. (JP) 2009-12-03 US disclosed
US-20090297979-A1 Polymerizable compound, polymer, positive resist composition, and patterning process using the same SHIN-ETSU CHEMICAL CO., LTD. (JP) 2009-12-03 US disclosed
US-20090297979-A1 Polymerizable compound, polymer, positive resist composition, and patterning process using the same SHIN-ETSU CHEMICAL CO., LTD. (JP) 2009-12-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090297979-A1 Polymerizable compound, polymer, positive resist composition, and patterning process using the same PRRC2A, PUF60, POLR2B TAS1R3 1997/4885TAS1R1 1768/4885SNCA 4774/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.